Browsing: Congenital hyperinsulinemia hypoglycemia

Avexitide (Eiger Biopharmaceuticals), a first-in-class GLP receptor blocker, has significantly reduced hypoglycemia in patients with refractory post-obesity hypoglycemia, a new…